The American College of Rheumatology and National Psoriasis Foundation released new guidelines on the management of active psoriatic arthritis among treatment‐naïve individuals.

News

News
Monday, December 21, 2015
Apremilast, an oral phosphodiesterase-4 inhibitor, can reduce the severity of nail and scalp psoriasis. 
News
Friday, May 8, 2015
Off label use of biologics for an increasing array of skin diseases is becoming more common as researchers learn more about these drugs, particularly newer generation biologics.